Similar companies
Cyclerion Therapeutics X Follower Count
Cyclerion Therapeutics has 347 followers on X (formerly Twitter), down 1.4% over the past three months. Losing followers on X can indicate declining public interest or brand sentiment challenges.
With 347 followers, Cyclerion Therapeutics has a smaller X following than industry peers like Amgen (118,624) and Gilead Sciences (72,279).
How Cyclerion Therapeutics’s X Growth Feeds the CYCN AI Score
X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Cyclerion Therapeutics’s X following into the CYCN AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.
For Cyclerion Therapeutics’s reach on other platforms, see Cyclerion Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.
For real-time conversation volume, see CYCN X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.
Month over Month
| Aug 2026 | 346 | |
| Jul 2026 | 349 | |
| Jun 2026 | 352 | |
| May 2026 | 351 |
Cyclerion Therapeutics X (Twitter) Followers: Frequently Asked Questions
Cyclerion Therapeutics has 347 followers (347) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.
Cyclerion Therapeutics's X following is declining, down 1.4% over the past three months. View the trend chart above for the full history.
X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Cyclerion Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Cyclerion Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Cyclerion Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.
With fewer than 1,000 followers, Cyclerion Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.
Sign up and get more insights on Cyclerion Therapeutics.
See Cyclerion Therapeutics’s complete x followers history
Sign up to unlock 1-year and all-time charts for CYCN, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
